Caxton Associates »

Abcellera Biologics shares owned by Caxton Associates

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Caxton Associates from 13F filings

Historical chart of Caxton Associates investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Caxton Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Caxton Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.8M 358k 5.03

More positions owned by Caxton Associates

Tesla Motors (TSLA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Intel Corporation (INTC)
Kellogg Company Put Option (K)
Ishares Msci Mexico Etf (EWW)
Uranium Energy (UEC)
Ishares Msci Brazil Etf (EWZ)
Cameco Corporation (CCJ)
Netflix (NFLX)
Frontier Communications Pare (FYBR)
Kraneshares Trust Csi Chi Internet (KWEB)
Sandisk Corp Put Option (SNDK)

View all positions for Caxton Associates

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Baillie Gifford & Co
Two Sigma Investments
Two Sigma Advisers
Arrowpoint Asset Management
BlackRock
Renaissance Technologies
Tang Capital Management
UBS Group
Millennium Management
Susquehanna International
Guardian Partners
Driehaus Capital Management
Citadel Advisors

View all funds holding Abcellera Biologics